View in EDS

Results of a randomized phase 2 study of PD 0332991, a cyclin-dependent kinase (CDK) 4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (BC).

Saved in:
Bibliographic Details
Title: Results of a randomized phase 2 study of PD 0332991, a cyclin-dependent kinase (CDK) 4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (BC).
Authors: Finn, R. S., Crown, J. P., Lang, I., Boer, K., Bondarenko, I. M., Kulyk, S. O., Ettl, J., Patel, R., Pinter, T., Schmidt, M., Shparyk, Y., Thummala, A. R., Voytko, N. L., Breazna, A., Kim, S. T., Randolph, S., Slamon, D. J.
Source: Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p2171-2171. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 86072689
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Results of a randomized phase 2 study of PD 0332991, a cyclin-dependent kinase (CDK) 4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (BC).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Finn%2C+R%2E+S%2E%22">Finn, R. S.</searchLink><br /><searchLink fieldCode="AR" term="%22Crown%2C+J%2E+P%2E%22">Crown, J. P.</searchLink><br /><searchLink fieldCode="AR" term="%22Lang%2C+I%2E%22">Lang, I.</searchLink><br /><searchLink fieldCode="AR" term="%22Boer%2C+K%2E%22">Boer, K.</searchLink><br /><searchLink fieldCode="AR" term="%22Bondarenko%2C+I%2E+M%2E%22">Bondarenko, I. M.</searchLink><br /><searchLink fieldCode="AR" term="%22Kulyk%2C+S%2E+O%2E%22">Kulyk, S. O.</searchLink><br /><searchLink fieldCode="AR" term="%22Ettl%2C+J%2E%22">Ettl, J.</searchLink><br /><searchLink fieldCode="AR" term="%22Patel%2C+R%2E%22">Patel, R.</searchLink><br /><searchLink fieldCode="AR" term="%22Pinter%2C+T%2E%22">Pinter, T.</searchLink><br /><searchLink fieldCode="AR" term="%22Schmidt%2C+M%2E%22">Schmidt, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Shparyk%2C+Y%2E%22">Shparyk, Y.</searchLink><br /><searchLink fieldCode="AR" term="%22Thummala%2C+A%2E+R%2E%22">Thummala, A. R.</searchLink><br /><searchLink fieldCode="AR" term="%22Voytko%2C+N%2E+L%2E%22">Voytko, N. L.</searchLink><br /><searchLink fieldCode="AR" term="%22Breazna%2C+A%2E%22">Breazna, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Kim%2C+S%2E+T%2E%22">Kim, S. T.</searchLink><br /><searchLink fieldCode="AR" term="%22Randolph%2C+S%2E%22">Randolph, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Slamon%2C+D%2E+J%2E%22">Slamon, D. J.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Cancer+Research%22">Cancer Research</searchLink>. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p2171-2171. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=86072689
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/0008-5472.SABCS12-S1-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: 2171
    Titles:
      – TitleFull: Results of a randomized phase 2 study of PD 0332991, a cyclin-dependent kinase (CDK) 4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (BC).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Finn, R. S.
      – PersonEntity:
          Name:
            NameFull: Crown, J. P.
      – PersonEntity:
          Name:
            NameFull: Lang, I.
      – PersonEntity:
          Name:
            NameFull: Boer, K.
      – PersonEntity:
          Name:
            NameFull: Bondarenko, I. M.
      – PersonEntity:
          Name:
            NameFull: Kulyk, S. O.
      – PersonEntity:
          Name:
            NameFull: Ettl, J.
      – PersonEntity:
          Name:
            NameFull: Patel, R.
      – PersonEntity:
          Name:
            NameFull: Pinter, T.
      – PersonEntity:
          Name:
            NameFull: Schmidt, M.
      – PersonEntity:
          Name:
            NameFull: Shparyk, Y.
      – PersonEntity:
          Name:
            NameFull: Thummala, A. R.
      – PersonEntity:
          Name:
            NameFull: Voytko, N. L.
      – PersonEntity:
          Name:
            NameFull: Breazna, A.
      – PersonEntity:
          Name:
            NameFull: Kim, S. T.
      – PersonEntity:
          Name:
            NameFull: Randolph, S.
      – PersonEntity:
          Name:
            NameFull: Slamon, D. J.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 12
              Text: Dec2012 Meeting Abstracts
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-print
              Value: 00085472
          Numbering:
            – Type: volume
              Value: 72
            – Type: issue
              Value: 24a
          Titles:
            – TitleFull: Cancer Research
              Type: main
ResultId 1